Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial
Titel:
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial
Auteur:
Schopohl, Jochen Gu, Feng Rubens, Robert Gaal, Luc Van Bertherat, Jérôme Ligueros-Saylan, Monica Trovato, Andrew Hughes, Gareth Salgado, Luiz R. Boscaro, Marco Pivonello, Rosario